What is Prostate Cancer? Cancer that develops in the prostate is known as prostate cancer. Many prostate cancers are limited to the prostate gland and grow slowly; thus, they might not be very to prostate cancer. A family history of prostate cancer or other cancers, such as breast or ovarian cancer, increases the likely to develop prostate cancer.

According to the American Cancer Society, prostate cancer remains a leading cause of cancer diagnoses What Is Prostate Cancer? Warning Signs of Advanced Prostate Cancer When prostate cancer spreads beyond the gland, more severe Prostate Cancer Risk Factors Understanding prostate cancer risk factors helps men make informed decisions PSA Test for Prostate Cancer The PSA test for prostate cancer measures prostate-specific antigen levels

Understanding Prostate Health The prostate is a small gland located below the bladder. Do Prostate Supplements Really Work? Many men ask: Do prostate supplements work? cancer, certain ingredients have shown promising results in supporting prostate function and reducing Benefits: Supports prostate cell health May lower oxidative stress Linked to reduced prostate cancer cancer.

Benign prostatic hyperplasia, or BPH, is a common condition in which the prostate becomes enlarged without being cancerous. Shrink the prostate immediately Eliminate the need for medical care Prevent prostate cancer Work for , while 5-alpha reductase inhibitors can help slow prostate growth or shrink the prostate in some men prostate-shrinking medicines.

Rucaparib is one such targeted therapy used to treat certain ovarian and prostate cancers, offering hope Key Takeaways Rucaparib is a targeted therapy used for specific ovarian and prostate cancers. Doctors may prescribe Rucaparib for: Certain recurrent ovarian cancers Fallopian tube cancer Primary peritoneal cancer Selected cases of metastatic prostate cancer with BRCA mutations Because eligibility cancers in eligible patients. 2.

From detecting breast cancer in mammograms to identifying lung cancer in CT scans, AI-powered technologies detecting multiple cancer types. and other skin cancers. Prostate Cancer AI helps analyze MRI images and biopsy samples to improve prostate cancer diagnosis. AI is currently used in detecting breast, lung, skin, colorectal, prostate, brain, and liver cancers,

colorectal, stomach, and lung cancer. , colorectal, pancreatic, and kidney cancer. Protect Your Skin from the Sun Skin cancer is one of the most common cancers, but it is highly preventable Follow recommended guidelines: Screening tests for breast, cervical, colorectal, and prostate cancers Q5: Is stress a direct cause of cancer?

liquid biopsy applications for: Breast cancer Lung cancer Colon cancer Prostate cancer Ovarian cancer Targeted cancer therapy focuses on specific genetic mutations that drive cancer growth. Recent discoveries have led to new targeted drugs for: Lung cancer Breast cancer Colorectal cancer Leukemia cancer. Advances in personalized cancer vaccines, immunotherapy for cancer, AI-powered early cancer detection

cells, including breast cancer cells. Research has focused on whether ivermectin may help: Slow cancer cell growth Trigger cancer cell death Understanding Breast Cancer Breast Cancer occurs when abnormal breast cells grow uncontrollably. breast cancer Triple-negative breast cancer Inflammatory breast cancer Treatment options usually include and cancer stem cells.

The National Cancer Institute review of curcumin and cancer reports that early-phase prevention studies Usually not for cancer prevention. cancer, selectively killing cancer cells, or outperforming chemotherapy. Which spice is best for preventing cancer? No spice has been proven to prevent cancer. Can garlic lower cancer risk?

In 2026, the growing interest in repurposed drugs for cancer therapy continues to shape cancer research Rising Cancer Cases Worldwide Cancer remains one of the leading causes of death globally. Affordable Cancer Treatments Many cancer therapies are extremely expensive. Focus on Rare Cancers Rare cancers often receive less research funding. FAQs About Repurposed Drugs for Cancer Therapy 1 What are repurposed drugs in cancer treatment?

Why Diet Matters in Cancer Prevention Researchers estimate that a significant percentage of cancer cases Top Foods That May Help Lower Cancer Risk 1. How important is fiber for cancer prevention? Can diet alone prevent cancer? No. What is the best anti-cancer diet?

It is not approved for cancer treatment in humans. Why Did Fenbendazole Become Associated With Cancer Treatment? , in certain cancer cell lines exposed to fenbendazole. What Do Cancer Organizations and Experts Say? as a proven cancer therapy.

Why cancer researchers became interested Cancer cells often divide quickly and depend on structures called and effects on both cancer cells and experimentally defined cancer stem cells. cancer in people. Cancer therapy is highly individual, and interruptions can matter depending on the cancer type, stage Has fenbendazole cured cancer in humans?

Medically reviewed by Jonathan Reed, Medical Content Reviewer on Aug 12 2026 Introduction Receiving a lung cancer Key Takeaways Tagrisso is a targeted therapy for certain EGFR-mutated non-small cell lung cancer patients osimertinib) is an oral targeted therapy approved for treating specific types of EGFR-positive lung cancer Certain patients whose cancer has developed resistance to earlier EGFR therapies Because treatment often Financial challenges should never become a reason to delay conversations about cancer treatment.

Written by Elizabeth Chernoby in TheSkyMeds Editorial Standards Medically reviewed by Jonathan Reed, Medical Content Reviewer Nov 25 2025 Since the first antiviral options appeared in 2020, the COVID-19 treatment landscape has matured: oral antivirals that stop viral replication are now the backbone of early outpatient care for people at higher risk of severe disease, and new candidates aim to expand options for treatment and even prevention. This update summarizes the treatments clinicians currently use, what’s new (including promising drugs under review), how they’re used, and practical FAQs for patients. 1. Nirmatrelvir–ritonavir Paxlovid remains the most commonly recommended oral antiviral for non-hospitalized adults at risk of progression to severe COVID-19. When started early (ideally within 5 days of symptom onset), it has consistently reduced hospitalizations and deaths in clinical trials and real-world studies. Because ritonavir strongly interacts with many commonly used drugs, clinicians must check for drug–drug interactions before prescribing. The CDC and treatment guidelines continue to list Paxlovid as a first-line outpatient option. 2. Remdesivir Originally used in hospitalized patients, remdesivir—given intravenously—has evidence supporting early use in high-risk outpatients as well. Some guideline panels recommend remdesivir for high-risk patients with mild-to-moderate COVID-19 when oral options aren’t suitable. Remdesivir’s label and guidance have been updated in recent years to reflect broader clinical experience. 3. Molnupiravir Molnupiravir is an oral antiviral option reserved for situations where Paxlovid and remdesivir aren’t appropriate or available. It showed more modest reductions in severe outcomes relative to Paxlovid in trials and real-world studies; many guidelines therefore place it as an alternative rather than first choice. Concerns about lower efficacy and regulatory differences across countries mean its use is more limited. 4. Newer oral agents Several newer oral protease inhibitors have emerged. One notable example is ensitrelvir (marketed as Xocova in Japan), which has been approved in Japan and Singapore and—in 2025—was submitted to the U.S. FDA for review, including study data suggesting it may reduce the risk of infection when given shortly after exposure in household settings. Regulatory decisions and availability outside Asia are evolving. These drugs expand options, but approval status and recommended indications vary by country. Important clinical points Timing matters. Antivirals work best when given early in the course of infection (generally within 5 days of symptom onset for most oral agents). Delayed treatment is less effective. Drug interactions are real. Ritonavir (part of Paxlovid) is a strong cytochrome P450 inhibitor and can dangerously raise or lower levels of many medicines (statins, some antiarrhythmics, certain immunosuppressants, etc.). A drug-interaction check is mandatory. Rebound can occur. Some patients experience symptom recurrence or a new positive test a few days after finishing Paxlovid (“COVID rebound”). Most rebound cases are mild and self-limited; public health agencies emphasize that the benefits of Paxlovid in preventing severe disease outweigh the small chance of rebound. Variants and resistance. Antivirals that target the virus (like protease inhibitors and polymerase inhibitors) may be affected by viral evolution. So far, major oral antivirals retain clinical effectiveness across recent Omicron-era variants, but surveillance continues. New drugs aim to broaden the arsenal and reduce the likelihood of resistance. Access, supply and public health guidance In many countries, public health agencies maintain supplies and distribution pathways for antivirals. For example, the U.S. federal program continues to manage Paxlovid access for certain settings, while clinicians can also prescribe directly where available. Availability differs by country and over time, so local health department and prescribing guidance should be consulted. Conclusion Antivirals remain a key tool to prevent severe COVID-19 when started early, with Paxlovid as the most widely used outpatient option and remdesivir and molnupiravir serving as alternatives in specific situations. New entrants like ensitrelvir could expand choices and—uniquely—offer post-exposure prevention in some contexts. Talk to your healthcare provider quickly after a positive test if you’re at higher risk, because timing is crucial. FAQs Q: If I test positive for COVID-19, should I take an antiviral? A: If you’re at increased risk of severe COVID-19 (older age, immunocompromise, certain chronic conditions), contact your healthcare provider immediately; treatment started within a few days of symptom onset offers the most benefit. If you’re low risk, antiviral treatment often isn’t necessary. Q: Is Paxlovid safe and who should avoid it? A: Paxlovid is effective and generally safe but interacts with many medications. People taking drugs that can’t be safely paused or adjusted (certain antiarrhythmics, anticoagulants, immunosuppressants, some statins) may need alternative therapy. Always consult a prescriber who will check interactions. Q: What is “Paxlovid rebound” and how worried should I be? A: Rebound is recurrence of symptoms or a new positive test a few days after recovery. It can happen with or without antivirals and is usually mild. If rebound occurs, resume isolation and contact your healthcare provider if symptoms worsen. Q: How does remdesivir fit in if it’s IV? A: Remdesivir is used mainly in hospitalized patients, but short-course IV remdesivir has also been used in high-risk outpatients when oral pills aren’t an option. Logistics (IV access, infusion setting) make it less convenient than oral pills. Q: Are new drugs like ensitrelvir available in my country? A: Ensitrelvir is approved in some countries (e.g., Japan, Singapore). Regulatory reviews are ongoing elsewhere—check local health authorities for approval status and availability. Q: Will antivirals prevent Long COVID? A: Data are mixed. Some studies suggest early antivirals may reduce the risk of long-term complications for some patients, but evidence is not definitive. Research continues.

Medically reviewed by Jonathan Reed, Medical Content Reviewer Jul 25 2026 Introduction The cost of cancer While targeted therapies have transformed outcomes for many people with lung cancer, they can also create Osimertinib is among the most effective medications for certain EGFR-positive non-small cell lung cancers Key Takeaways Osimertinib 80 mg is primarily used to treat EGFR-mutated non-small cell lung cancer. It works by blocking abnormal proteins that help cancer cells grow while targeting resistant mutations

While Lenvima 10mg has helped improve outcomes for many people living with certain cancers, knowing It works by blocking proteins that help cancer cells grow and develop new blood vessels. : Differentiated thyroid cancer Renal cell carcinoma (kidney cancer) Hepatocellular carcinoma (liver cancer) Endometrial cancer (in combination with other medicines) Instead of directly attacking all rapidly Managing side effects early is just as important as treating the cancer itself.